This glucagon-like peptide-1 (GLP-1) receptor agonist encourages insulin secretion from the pancreas, slows gastric emptying, and reduces appetite, resulting in higher energy expenditure and lower food consumption
PlexusDx sources all compounded medications from licensed 503A compounding pharmacies, which must meet FDA standards for sterility, strength, and purity
5-Amino-1MQ is a small-molecule NNMT pathway inhibitor analog studied in enzymatic and metabolic research systems
Adaptogenic Support: The immune-boosting properties of the injection may provide adaptogenic support, helping the body better cope with stress and environmental challenges
Baseline and periodic testing of metabolic markers, hormone levels, and organ function provides objective feedback about protocol effects